Drug – bio-affecting and body treating compositions – Dentifrices
Reexamination Certificate
1999-03-02
2001-02-20
Rose, Shep K. (Department: 1614)
Drug, bio-affecting and body treating compositions
Dentifrices
Reexamination Certificate
active
06190643
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to a method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention of dental caries and gingivitis, and for prevention of treatment of periapical infections, and whitening and/or mechanical cleaning of an individual's teeth.
BACKGROUND OF THE INVENTION
The publications and other materials used herein to illuminate the background of the invention, and in particular, cases to provide additional details respecting the practice, are incorporated by reference.
Bioactive glasses have been tested as substitutes for reconstruction of defects of the facial bones (
1
), rehabilitation of the dentoalveolar complex (
2
), regeneration of periodontal pockets (
3
), and recently also for treatment of hypersensitive teeth (
4
). The surface reactive bioactive glass contains SiO
2
, Na
2
O, CaO and P
2
O
5
. The chemical bond with bone in vivo is reported to result from the leaching of Na
+
-ions and the congruent dissolution of calcium, phosphate and silica from the glass in an aqueous environment, giving rise to an Si-rich layer on the material. The Si-rich layer acts as a templet for a calcium phosphate precipitation, which then binds to the bone (
5
). Bioactive glass has been successfully used for reconstructions of closed bone defects, which are not exposed to the external environment after the clinical procedure (
1
). However, there are a number of conditions for which bioactive glasses are used as therapeutic materials but that, at the same time, are imminently prone to microbial infections. These include clinical conditions such as infected frontal minuses (
6
), periodontal pockets (
3
) and hypersensitive teeth as a complication of periodontal treatment or tooth wear that has resulted in the exposure of dentin and dentinal tubules (
4
). Obviously, the demonstration of any antibacterial activity of the bioactive glass would add to the therapeutic vale of the material in the clinical conditions described. Earlier studies have shown that
P. gingivalis
is agglutinated in the presence of granules (315-500 &mgr;m) of the bioactive glass S53P4 in an aqueous environment due to Ca
+
-ions released from the granules (
19
,
7
). The minimum Ca
+
-concentration needed to induce agglutination of
P. gingivalis
was found to be 0.04 g/l (
7
). In these studies, however, no reduction of the viability of the bacteria was noticed.
Earlier studies have shown that the bioactive glass can act as a vehicle for Ca
2+
, PO
4
3−
, Na
+
and Si
4+
, which then mineralise type I collagen and enhance mineral formation in the dentinal tubules. Therefore, an aqueous preparation comprising bioactive glass may have potential to be used as a paste for the treatment of hypersensitive teeth with recessed gingival margins and exposed dentins. Positive affects of such a treatment have been obtained already after 10 to 60 min, which makes this particular material interesting even from a clinical point of view (
4
).
OBJECT AND SUMMARY OF THE INVENTION
The object of the present invention is to provide an easy, quick and safe method to reduce the viability of detrimental oral microorganisms in an individual. A particular object is to achieve a method which is not based on use of antibiotic drugs associated with the risk of causing microbe resistance.
A particular object is to provide a method to reduce the viability of cariogenic bacteria and periodontal bacteria.
Another particular object is to provide a method to effectively reduce the viability of the detrimental oral microorganisms while the viability of non-pathogenic oral micro-organisms is reduced to a lesser degree.
A further object of this invention is to provide methods for prevention of dental caries and/or gingivitis, and for whitening of an individual's teeth, wherein said methods are due to the reduction of the viability and thus the decrease of the number of the detrimental oral micro-organisms.
Still one object is to achieve mechanical cleaning and whitening of an individual's teeth, wherein the whitening is a result of said mechanical cleaning.
Thus, according to the aspect, the invention concerns a method for reducing the viability of detrimental oral microorganisms in an individual, said method comprising subjecting the individual's oral cavity to a bioactive glass, the average particle size of which is less than 100 &mgr;m.
According to another aspect, the invention concerns a method for the prevention of dental caries and/or gingivitis in an individual, said caries being caused by a cariogenic bacteria, or for prevention or treatment of periapical infections, said method comprising subjecting the individual's oral cavity and/or root canals to a bioactive glass, the average particle size of which is less than 100 &mgr;m.
According to a further aspect, this invention concerns a method for the whitening of an individual's teeth, said method comprising subjecting the individual's oral cavity to a bioactive glass, the average particle size of which is less than 100 &mgr;m.
REFERENCES:
patent: 4189325 (1980-02-01), Barrett et al.
patent: 4725234 (1988-02-01), Ethridge
patent: 4737411 (1988-04-01), Graves et al.
patent: 4775592 (1988-10-01), Akahane et al.
patent: 4783429 (1988-11-01), Shibuya et al.
patent: 4839215 (1989-06-01), Starling et al.
patent: 4851046 (1989-07-01), Low et al.
patent: 5034353 (1991-07-01), Shibuya et al.
patent: 5074916 (1991-12-01), Hench et al.
patent: 5432130 (1995-07-01), Rheinberger et al.
patent: 5681872 (1997-10-01), Erbe
patent: 5735942 (1998-04-01), Litkowski et al.
patent: 5891233 (1999-04-01), Salonen et al.
patent: 07300339 (1975-11-01), None
patent: 08048539 (1996-02-01), None
patent: 08012512 (1996-11-01), None
patent: 96/21628 (1996-07-01), None
patent: WO 97/27148 (1997-07-01), None
patent: 99/13852 (1999-03-01), None
Stoor Acta Odontologica Scand 56: 161-163, 1998.
*Absi, et al., “Dentine hypersensitivity: uptake of toothpastes onto dentine and effects of brushing, washing and dietary acid—SEM in vitro study”, 22J. of Oral Rehabilition175-182 (1995).
*Addy, et al., “Dentine hypersensitivity. II. Effects produced by the uptake in vitro of toothpastes on dentine”, 16J. of Oral Rehabilition35-48 (1989).
Andersson, “The Bioactivity of Silicate Glass”, Thesis, Dept of Chem Engineering. Åbo Akademi University, Finland (1990).
Larmas, et al., “Bioactive Glass in Periodontal Bone Defects. Initial Clinical Findings of Soft Tissue and Osseus Repair”, 8Bioceramics279-284 (1995).
Yamashita, et al., “Effect of Calcuim Ions on Cell Surface Electrostatics of Bacteroides gingivalis and Other Oral Bacteria”, 275Zentralblatt fur Bacteriologie. 46-53 (1991).
Greenwood, “Morphology and Nature of Micro-organisms”,Medical Microbiology11-30 (14th ed., 1992).
Nolte, “Physiology and Growth of Microorganisms”,Oral Microbiology25-38 (3rd ed., 1977).
Slots, “The Predominant cultivable microflora of advanced periodontitis”, 85Scand. J. Dent. Res. 114-121 (1977).
Slots, “The predominant cultivable organisms in juvenile periodontitis”, 84Scand. J. Dent. Res. 1-10 (1976).
Wilson et al., “Clinical Appication of Bioglass Implants”, 7Bioceramics415-422 (1994).
Aitasalo, et al, “Behaviour of Bioactive Glass (S53P4) in Human Frontal Sinus Obliteration”, 10Bioceramics429-432 (1997).
Cimasoni et al.,Crevicular Fluid Updated, 70-71 (2nd ed., 1983).
Burnett et al., “Dental Caries”,Oral Microbiology and Infectious Disease193-197 (1978).
Andersson et al., “Dissolution, leaching, and Al2O3enrichment at the surface of bioactive glasses studied by solution analysis”, 27J. Biomed. Mat. Res. 941-948 (1993).
Hench et al., “Direct Chemical Bond of Bioactive Glass-Ceramic Materials to Bone and Muscle”, 4J. Biomed. Mater. Res. Symposium25-42 (1973).
Morrier et al., “Antibacterial action of dental cements: An in vitro study”, 38Bull Group Int Rech Sci Stomatol et Odontal, 87-93 (1995).
Tanner, et al., “A study of the bacteria associated with andvancing periodontitis in man”, 6J. Clinical Periodon
Salonen Jukka
Soderling Eva
Stoor Patricia
Yli-Urpo Antti
Lydon James C.
Rose Shep K.
LandOfFree
Method for reducing the viability of detrimental oral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing the viability of detrimental oral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing the viability of detrimental oral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2602470